Methylprednisolone Alphapharm

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

اشتر الآن

العنصر النشط:

Methylprednisolone sodium succinate

متاح من:

Alphapharm Pty Ltd

الفئة:

Medicine Registered

نشرة المعلومات

                                METHYLPREDNISOLONE
ALPHAPHARM
 
_contains the active ingredient methylprednisolone sodium succinate_
CONSUMER MEDICINE INFORMATION
   
 
 
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Methylprednisolone
Alphapharm.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have benefits and
risks. Your doctor has weighed the
risks of you taking
Methylprednisolone Alphapharm
against the benefits expected for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, TALK TO YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH YOUR
MEDICINE.
You may need to read it again.
WHAT
METHYLPREDNISOLONE
ALPHAPHARM IS USED
FOR
Methylprednisolone Alphapharm is
used for the treatment of one or more
of the following:
•
skin diseases
•
allergic reactions
•
inflammation of the eyes
•
respiratory diseases and certain
respiratory infections
•
diseases of the gut
(gastrointestinal tract)
•
multiple sclerosis
•
rheumatic disorders
•
diseases of the blood
•
treatment of certain glandular
conditions
Methylprednisolone sodium
succinate, the active ingredient in
Methylprednisolone Alphapharm,
belongs to a group of medicines
called corticosteroids.
Methylprednisolone Alphapharm acts
in the body by reducing
inflammation (pain, swelling, redness
and heat), which is one of the body's
reactions to injury, and by reducing
the body's reaction to infection.
Your doctor may have prescribed
Methylprednisolone Alphapharm for
another reason.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT
METHYLPREDNISOLONE ALPHAPHARM.
Methylprednisolone Alphapharm is
available only with a doctor's
prescription.
There is no evidence that
Methylprednisolone Alphapharm is
addictive.
BEFORE YOU START
TREATMENT WITH
METHYLPREDNISOLONE
ALPHAPHARM
_WHEN YOU MUST NOT TAKE IT_
DO NOT TAKE METHYLPREDNISOLONE
ALPHAPHARM IF:
•
YOU HAVE AN ALLERGY TO ANY
MEDICINE CONTAINING
METHYLPREDNISOLONE
•
YOU HAVE AN ALLERGY TO ANY
INGREDIENTS LISTED AT THE END OF
                                
                                اقرأ الوثيقة كاملة
                                
                            

خصائص المنتج

                                METHYLPREDNISOLONE ALPHAPHARM 
POWDER FOR INJECTION  
_Methylprednisolone (as sodium succinate) _
 
PRODUCT INFORMATION 
NAME OF THE MEDICINE 
Active ingredient: 
Methylprednisolone sodium succinate 
Chemical name: 
Pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-
,monosodium salt,(6α,11β) 
Structural formula: 
 
 
Molecular formula:  
C
26
H
33
NaO
8
  
 
 
 
 
 
 
Molecular weight:  496.53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CAS Registry No:  2375-03-3 
DESCRIPTION 
Methylprednisolone Alphapharm contains methylprednisolone sodium succinate, a synthetic glucocorticoid. It 
occurs as a white or nearly white, odourless, hygroscopic, amorphous solid. It is very soluble in water and in 
alcohol; it is insoluble in chloroform and is very slightly soluble in acetone.  
Methylprednisolone sodium succinate is so extremely soluble in water that it may be administered in a small 
volume of diluent and is especially well suited for intravenous use in situations in which high blood levels of 
methylprednisolone are required rapidly. 
Methylprednisolone  Alphapharm  40  mg,  powder  for  injection  (IM-IV)  contains  the  active  ingredient, 
methylprednisolone. It also contains the following excipients: sodium phosphate monobasic anhydrous, sodium 
phosphate  dibasic  anhydrous,  sodium  hydroxide  and  lactose  anhydrous.  It  is  intended  for  intramuscular  or 
intravenous administration.  
Methylprednisolone  Alphapharm  500  mg  and  1  g,  powder  for  injection  (IV)  contain  the  active  ingredient, 
methylprednisolone. They also contain the following excipients: sodium phosphate monobasic anhydrous, sodium 
phosphate dibasic anhydrous and sodium hydroxide, and are indicated for intravenous administration only. 
IMPO
                                
                                اقرأ الوثيقة كاملة
                                
                            

تنبيهات البحث المتعلقة بهذا المنتج

عرض محفوظات المستندات